Market capitalization | SEK5.19b |
Enterprise Value | SEK5.09b |
P/E (TTM) P/E ratio | 34.54 |
EV/FCF (TTM) EV/FCF | 23.90 |
EV/Sales (TTM) EV/Sales | 6.90 |
P/S ratio (TTM) P/S ratio | 7.04 |
P/B ratio (TTM) P/B ratio | 6.76 |
Dividend yield | 1.03% |
Last dividend (FY23) | SEK2.25 |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
3 Analysts have issued a CellaVision forecast:
3 Analysts have issued a CellaVision forecast:
Sep '24 |
+/-
%
|
||
Revenue | 737 737 |
17%
17%
|
|
Gross Profit | 494 494 |
15%
15%
|
|
EBITDA | 229 229 |
9%
9%
|
EBIT (Operating Income) EBIT | 189 189 |
32%
32%
|
Net Profit | 150 150 |
34%
34%
|
In millions SEK.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
CellaVision AB engages in the provision of digital microscopy solutions for hematology laboratories. The firm's products include Analyzers, Instruments, DIFF-Line™ by CellaVision, Reagents, and Software and applications. It operates through the following geographical segments: Americas, APAC, and EMEA. The company was founded by Lars Christer Fedrik Fåhraeus on November 16, 1994 and is headquartered in Lund, Sweden.
Head office | Sweden |
CEO | Simon Ostergaard |
Employees | 228 |
Founded | 1994 |
Website | www.cellavision.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.